LAM cells from women with sporadic LAM can carry somatic mutations in the TSC2 gene, which is a tumor suppressor gene that regulates the mammalian Target of Rapamycin (mTOR) [4], [5], [6], [7], [8]. The gene discussed is TSC2; the disease is lymphangioleiomyomatosis.